KAKEN PHARMACEUTIAL CO., LTD.
Develops and markets pharmaceuticals for dermatology, orthopedics, and surgery.
4521 | T
Overview
Corporate Details
- ISIN(s):
- JP3207000005
- LEI:
- Country:
- Japan
- Address:
- 文京区本駒込二丁目２８番８号
- Website:
- https://www.kaken.co.jp/english/
- Sector:
- Manufacturing
Description
Kaken Pharmaceutical Co., Ltd. is a research and development-driven company that develops, manufactures, and markets prescription pharmaceuticals, medical equipment, and agrochemicals. The company's primary focus is on pharmaceuticals, with significant expertise in dermatology, orthopedics, and surgery. Its portfolio of main products includes Clenafin for onychomycosis, Artz for osteoarthritis, Fiblast for wound healing, and Ecclock for primary axillary hyperhidrosis. Kaken's research and development efforts are concentrated on specific fields, including the immune system, nervous system, and infectious diseases, to create innovative drugs. The company also has business activities in real estate.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-29 07:30 |
内部統制報告書－第101期(令和2年4月1日－令和3年3月31日)
|
Japanese | 23.6 KB | ||
| 2021-06-29 07:28 |
有価証券報告書－第101期(令和2年4月1日－令和3年3月31日)
|
Japanese | 1.0 MB | ||
| 2021-02-10 03:36 |
四半期報告書－第101期第3四半期(令和2年10月1日－令和2年12月31日)
|
Japanese | 181.3 KB | ||
| 2020-11-12 02:31 |
四半期報告書－第101期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | 209.6 KB | ||
| 2020-08-12 02:53 |
四半期報告書－第101期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | 173.1 KB | ||
| 2020-06-26 04:13 |
有価証券報告書－第100期(平成31年4月1日－令和2年3月31日)
|
Japanese | 997.5 KB | ||
| 2020-02-13 01:05 |
四半期報告書－第100期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | 173.3 KB | ||
| 2019-11-13 01:20 |
四半期報告書－第100期第2四半期(2019/07/01－2019/09/30)
|
Japanese | 195.6 KB | ||
| 2019-08-09 02:26 |
四半期報告書－第100期第1四半期(2019/04/01－2019/06/30)
|
Japanese | 160.1 KB | ||
| 2019-06-27 04:44 |
有価証券報告書－第99期(平成30年4月1日－平成31年3月31日)
|
Japanese | 875.6 KB | ||
| 2019-02-13 01:21 |
四半期報告書－第99期第3四半期(2018/10/01－2018/12/31)
|
Japanese | 160.1 KB | ||
| 2018-11-12 02:14 |
四半期報告書－第99期第2四半期(2018/07/01－2018/09/30)
|
Japanese | 177.9 KB | ||
| 2018-08-10 02:16 |
四半期報告書－第99期第1四半期(2018/04/01－2018/06/30)
|
Japanese | 150.0 KB | ||
| 2018-06-28 06:07 |
有価証券報告書－第98期(平成29年4月1日－平成30年3月31日)
|
Japanese | 754.0 KB | ||
| 2018-02-13 01:34 |
四半期報告書－第98期第3四半期(2017/10/01－2017/12/31)
|
Japanese | 146.3 KB |
Automate Your Workflow. Get a real-time feed of all KAKEN PHARMACEUTIAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KAKEN PHARMACEUTIAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KAKEN PHARMACEUTIAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
